Orion Corporation

Oncology

Clinical research includes advanced solid tumours and metastatic castration-resistant prostate cancer, with attention to tumour control and antitumour activity in treatment-resistant disease.

  • Solid tumours
  • Metastatic castration-resistant prostate cancer
  • Antitumour activity

Work in this area reflects interest in difficult-to-treat malignancies and advanced oncology settings.

Neuropathic and Musculoskeletal Pain

Research activity covers chronic pain due to diabetic peripheral neuropathy and knee osteoarthritis, focusing on persistent pain conditions that affect daily function and mobility.

  • Diabetic peripheral neuropathy
  • Knee osteoarthritis
  • Chronic pain

This area centers on analgesic development for long-standing neuropathic and musculoskeletal symptoms.

Sleep Disorders

The sponsor funds studies in insomnia disorder and short-term treatment of insomnia, indicating a therapeutic focus on sleep initiation and maintenance problems.

  • Insomnia disorder
  • Short-term insomnia
  • Sleep disturbance

These trials address clinically relevant sleep medicine needs in both persistent and acute forms of insomnia.

Neurology and Movement Disorders

Clinical interest extends to Parkinson disease, including comparative work involving Parkinson’s disease treatments, alongside broader neurological evaluation in healthy volunteers.

  • Parkinson disease
  • Movement disorders
  • Neurological therapeutics

This domain reflects involvement in neurodegenerative disease research and treatment-related assessment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Tolerability of ODM-212 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Finland France Spain
  • Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

    Not yet recruiting

    1 1 1 1
    Denmark Finland France Spain
  • Study on the Effects of Tasipimidine for Patients with Insomnia Disorder

    Not recruiting

    2 1
    Investigated drugs:
    Finland Germany Poland
  • Study on the Effects and Safety of ODM-111 and Paracetamol for Chronic Knee Pain in Osteoarthritis Patients

    Not recruiting

    2 1 1
    Investigated drugs:
    Czechia Denmark Germany Poland Spain
  • Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

    Not recruiting

    2 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland
  • Study of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Finland France